Association of Self-Reported Depression on the Lupus Impact Tracker with Glucocorticoid Therapy and Fibromyalgia in Systemic Lupus Erythematosus: Insights from the RELESSER-PROS Registry - Takeaways - MDSpire

Association of Self-Reported Depression on the Lupus Impact Tracker with Glucocorticoid Therapy and Fibromyalgia in Systemic Lupus Erythematosus: Insights from the RELESSER-PROS Registry

  • By

  • Inigo Rua-Figueroa

  • Julia Martínez-Barrio

  • Zulema Plaza

  • Norman Jiménez

  • Maria Galindo-Izquierdo

  • Esther Uriarte

  • Antonio Fernandez-Nebro

  • Jaime Calvo Alen

  • José Rosas

  • Javier Narváez

  • Elena Aurrecoechea

  • Mercedes Freire

  • Eva Tomero

  • Clara Sanguesa

  • Carlota Iniguez

  • Ana Perez

  • Sandra Garrote

  • Nuria Lozano-Rivas

  • Oihane Ibarguengoitia

  • Eva Salgado

  • Celia Erausquin

  • Tarek Carlos Salman Monte

  • Raúl Menor

  • Irene Altabás-González

  • Jorge Fragio Gil

  • Joan M. Nolla

  • Jose M. Pego-Reigosa

  • January 24, 2026

  • 0 min

Share

  • 1

    The study assessed self-reported depression in systemic lupus erythematosus patients using the Lupus Impact Tracker (LITQ7).

  • 2

    A total of 89.9% of patients reported experiencing depression at least once, with 34.6% indicating persistent depressive symptoms.

  • 3

    Significant associations were found between self-reported depression and increased organ damage over time in SLE patients.

  • 4

    Glucocorticoid use and other covariates showed statistically significant changes during the study period.

  • 5

    The findings highlight the importance of patient-reported outcomes in understanding the emotional burden of SLE.

Original Source(s)

Association of Self-Reported Depression on the Lupus Impact Tracker with Glucocorticoid Therapy and Fibromyalgia in Systemic Lupus Erythematosus: Insights from the RELESSER-PROS Registry

  • by Inigo Rua-Figueroa, Julia Martínez-Barrio, Zulema Plaza, Norman Jiménez, Maria Galindo-Izquierdo, Esther Uriarte, Antonio Fernandez-Nebro, Jaime Calvo Alen, José Rosas, Javier Narváez, Elena Aurrecoechea, Mercedes Freire, Eva Tomero, Clara Sanguesa, Carlota Iniguez, Ana Perez, Sandra Garrote, Nuria Lozano-Rivas, Oihane Ibarguengoitia, Eva Salgado, Celia Erausquin, Tarek Carlos Salman Monte, Raúl Menor, Irene Altabás-González, Jorge Fragio Gil , Joan M. Nolla, Jose M. Pego-Reigosa

  • January 24, 2026

Related Content

Semaglutide Use Linked to Erythromelalgia Remission

Case details diagnostic workup and rapid symptom resolution following GLP-1 receptor agonist initiation.

Clinical applications and challenges of CD40/CD40L signaling regulation in autoimmune diseases

Plasmacytoid dendritic cells in systemic and cutaneous lupus erythematosus: an evolving understanding